GLAM
ALXN
Gardner Lewis Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-186,910
| Closed | -$34.3M | – | 102 |
|
|
2021
Q2 | $34.3M | Buy |
186,910
+116,910
| +167% | +$21.5M | 3.91% | 1 |
|
|
2021
Q1 | $10.7M | Buy |
+70,000
| New | +$10.7M | 1.92% | 18 |
|
|
2017
Q4 | – | Sell |
-9,425
| Closed | -$1.32M | – | 101 |
|
|
2017
Q3 | $1.32M | Buy |
+9,425
| New | +$1.32M | 0.08% | 83 |
|
|
2015
Q3 | – | Sell |
-22,390
| Closed | -$4.05M | – | 107 |
|
|
2015
Q2 | $4.05M | Sell |
22,390
-3,502
| -14% | -$633K | 0.61% | 49 |
|
|
2015
Q1 | $4.49M | Buy |
25,892
+1,155
| +5% | +$200K | 0.94% | 37 |
|
|
2014
Q4 | $4.58M | Sell |
24,737
-3,850
| -13% | -$712K | 0.92% | 36 |
|
|
2014
Q3 | $4.74M | Sell |
28,587
-320
| -1% | -$53.1K | 0.95% | 41 |
|
|
2014
Q2 | $4.52M | Sell |
28,907
-3,050
| -10% | -$477K | 1.25% | 30 |
|
|
2014
Q1 | $4.86M | Sell |
31,957
-155
| -0.5% | -$23.6K | 1.54% | 26 |
|
|
2013
Q4 | $4.27M | Buy |
32,112
+1,555
| +5% | +$207K | 1.44% | 28 |
|
|
2013
Q3 | $3.55M | Sell |
30,557
-198
| -0.6% | -$23K | 0.96% | 41 |
|
|
2013
Q2 | $2.84M | Buy |
+30,755
| New | +$2.84M | 0.73% | 59 |
|